Illumina | ILMN - Gross Profit On Sales


Illumina reported $759M in Gross Profit on Sales for its fiscal quarter ending in December of 2025.





Gross Profit On Sales Change Date
Agilent USD 946M 44M Dec/2025
Bio Techne USD 191.28M 3.16M Dec/2025
Bio-Rad Laboratories USD 343.4M 1.9M Sep/2025
Boston Scientific USD 3.61B 64M Mar/2026
Bruker USD 449.2M 69.8M Dec/2025
Charles River Laboratories USD 271.96M 39.43M Dec/2025
Danaher USD 3.59B 375M Mar/2026
Dentsply International USD 443M 2M Dec/2025
Edwards Lifesciences USD 1.29B 59.4M Mar/2026
Illumina USD 759M 26M Dec/2025
Intuitive Surgical USD 1.83B 73.8M Mar/2026
IQVIA Holdings USD 1.12B 32M Dec/2025
Laboratory Of America USD 993.2M 31.9M Dec/2025
Mettler Toledo International USD 675.44M 65.98M Dec/2025
Myriad Genetics USD 146.8M 3M Dec/2025
OraSure Technologies USD 11.34M 435K Dec/2025
Pacific Biosciences Of California USD 15.74M 601K Dec/2025
Quest Diagnostics USD 906M 33M Mar/2026
Quidel USD 274.8M 1.01B Dec/2025
Repligen USD 103.83M 3.32M Dec/2025
Revvity USD 421.66M 47.06M Dec/2025
Roche Holding CHF 22.09B 10.04B Dec/2025
Standard Biotools USD 11.38M 1.9M Dec/2025
Thermo Fisher Scientific USD 4.49B 146M Mar/2026
Waters USD 557.42M 97.44M Dec/2025